Phase II, Open-Label Trial to Assess the Activity of ZD1839 (IRESSA TM) in Patients With Recurrent Prostate Cancer Who Have Rising Serum PSA Levels Despite Serum Testosterone < 50mg/dl
收藏官方服务：
资源简介：
A study to assess the activity of Iressa in patients who's prostate cancer has recurred, and who have rising PSA levels
提供机构：
Vivli创建时间：
2020-10-30
